Sökning: "vandetanib"
Visar resultat 1 - 5 av 7 avhandlingar innehållade ordet vandetanib.
1. Prognostic Biomarkers and Target Proteins for Treatment of High-grade Gliomas
Sammanfattning : The survival for high-grade glioma patients is poor and the treatment may cause severe side effects. A common obstacle in the treatment is chemoresistance. To improve the quality of life and prolong survival for these patients prognostic biomarkers and new approaches for chemotherapy are needed. LÄS MER
2. Experimental combination therapy of brain cancer cell models
Sammanfattning : Epigenetic alterations and aberrant expression of genes controlling epigenetic mechanisms have been identified in several cancers, including medulloblastoma and glioma, the most common primary brain tumors in children and adults, respectively. We have been investigating if combination therapy using histone deacetylase inhibitors (HDACi) and receptor tyrosine kinase inhibitors (RTKi) will enhance glioblastoma and medulloblastoma cell killing. LÄS MER
3. Two novel combination therapies of glioblastoma multiforme from a Cx43 perspective : studies of in vitro models
Sammanfattning : The group of patients suffering from the malignant brain tumour glioblastoma multiforme (GBM) have a median survival of only about one year. Thus, new treatment strategies are urgently needed. Gap junctions are intercellular channels, permitting intercellular transfer of water soluble substances. LÄS MER
4. Multivariate analyses of proteomic and metabolomic patterns in brain tumors
Sammanfattning : Glioblastoma multiforme (GBM) is the most common primary brain tumor. Given the current standard of care, the prognosis for patients diagnosed with this disease is still poor. There consequently exists a need to improve current treatments, as well as to develop new ones. LÄS MER
5. Strategies for optimisation of 177Lu-octreotate therapy – exploring local administration and combination therapy regimens
Sammanfattning : Neuroendocrine tumours (NETs) are a group of heterogeneous tumour types that originate in hormone-producing organs. Patients with NETs are often diagnosed after the primary tumour has metastasised. LÄS MER